documents: FDA-2022-N-1794-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-N-1794-0004 | FDA | FDA-2022-N-1794 | Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products Guidance for Industry | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2024-11-12T23:47:18Z | 1 | 0 | 0900006485500486 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref